D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 81 Citations 25,417 238 World Ranking 9363 National Ranking 294

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Surgery

Nicolino Ruperto mostly deals with Internal medicine, Surgery, Rheumatology, Arthritis and Juvenile rheumatoid arthritis. Much of his study explores Internal medicine relationship to Physical therapy. His studies deal with areas such as Vasculitis, Polyarteritis nodosa, Clinical trial and Cohort study as well as Surgery.

Nicolino Ruperto has researched Rheumatology in several fields, including Mevalonate kinase deficiency, Rheumatism and Severity of illness. His Arthritis course of study focuses on Placebo and Clinical endpoint. He combines Juvenile rheumatoid arthritis and Juvenile Arthritis Disease Activity Score in his studies.

His most cited work include:

  • Preliminary definition of improvement in juvenile arthritis (888 citations)
  • EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. (680 citations)
  • EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides (553 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Internal medicine, Arthritis, Rheumatology, Physical therapy and Functional ability. As a part of the same scientific family, Nicolino Ruperto mostly works in the field of Internal medicine, focusing on Surgery and, on occasion, Macrophage activation syndrome. The study incorporates disciplines such as Placebo and Tocilizumab, Rheumatoid arthritis, Disease in addition to Arthritis.

His Rheumatology study integrates concerns from other disciplines, such as Etanercept, Pediatrics and Age of onset. His study in the field of Visual analogue scale is also linked to topics like Construct validity. The various areas that Nicolino Ruperto examines in his Functional ability study include Psychometrics and Gerontology.

He most often published in these fields:

  • Internal medicine (65.89%)
  • Arthritis (51.84%)
  • Rheumatology (40.47%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (65.89%)
  • Arthritis (51.84%)
  • Rheumatology (40.47%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Internal medicine, Arthritis, Rheumatology, Methotrexate and Family medicine. His research on Internal medicine frequently connects to adjacent areas such as Placebo. Nicolino Ruperto has included themes like Discontinuation, Adverse effect, Randomized controlled trial and Cohort in his Arthritis study.

His biological study deals with issues like Quality of life, which deal with fields such as Functional ability. The Rheumatology study combines topics in areas such as Psoriatic arthritis, Rheumatoid arthritis, Oligoarthritis, Orthopedic surgery and Juvenile dermatomyositis. His Methotrexate study integrates concerns from other disciplines, such as Gastroenterology and Prednisone.

Between 2018 and 2021, his most popular works were:

  • Classification criteria for autoinflammatory recurrent fevers (88 citations)
  • Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis. (34 citations)
  • Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study. (31 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Cancer

Nicolino Ruperto mainly investigates Internal medicine, Arthritis, Rheumatology, Juvenile Arthritis Disease Activity Score and Family medicine. His Methotrexate, Adverse effect, Receiver operating characteristic, Tocilizumab and Complete remission study are his primary interests in Internal medicine. His Arthritis study combines topics from a wide range of disciplines, such as Disease outcome, Pediatric Infectious Disease, Orthopedic surgery, Tuberculosis and Cohort.

The study incorporates disciplines such as MedDRA, Pharmacovigilance, Discontinuation, Consensus conference and Glucocorticoid in addition to Rheumatology. His Family medicine study combines topics in areas such as Clinical trial and Evidence-based medicine. His Clinical study design study in the realm of Clinical trial interacts with subjects such as Stakeholder.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Preliminary definition of improvement in juvenile arthritis

Edward H. Giannini;Nicolino Ruperto;Angelo Ravelli;Daniel J. Lovell.
Arthritis & Rheumatism (1997)

1235 Citations

EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria.

Seza Ozen;Angela Pistorio;Silvia M. Iusan;Aysin Bakkaloglu.
Annals of the Rheumatic Diseases (2010)

1061 Citations

EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides

Seza Ozen;Nicolino Ruperto;Michael Dillon;Arvind Bagga.
Annals of the Rheumatic Diseases (2005)

1001 Citations

2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features

Timothy Beukelman;Nivedita M. Patkar;Kenneth G. Saag;Sue Tolleson-Rinehart.
Arthritis Care and Research (2011)

838 Citations

Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.

Fabrizio De Benedetti;Hermine I. Brunner;Nicolino Ruperto;Andrew Kenwright.
The New England Journal of Medicine (2012)

744 Citations

Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis

Daniel J. Lovell;Nicolino Ruperto;Steven Goodman;Andreas Reiff.
The New England Journal of Medicine (2008)

660 Citations

Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis

Nicolino Ruperto;Hermine I. Brunner;Pierre Quartier;Tamás Constantin.
The New England Journal of Medicine (2012)

631 Citations

Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis

Carol A Wallace;Nicolino Ruperto;Edward Giannini.
The Journal of Rheumatology (2004)

599 Citations

Development and validation of a composite disease activity score for juvenile idiopathic arthritis.

Alessandro Consolaro;Nicolino Ruperto;Anna Bazso;Angela Pistorio.
Arthritis & Rheumatism (2009)

564 Citations

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

Nicolino Ruperto;Daniel J Lovell;Pierre Quartier;Eliana Paz.
The Lancet (2008)

556 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Nicolino Ruperto

Angelo Ravelli

Angelo Ravelli

Istituto Giannina Gaslini

Publications: 147

Seza Ozen

Seza Ozen

Hacettepe University

Publications: 119

Lucy R. Wedderburn

Lucy R. Wedderburn

University College London

Publications: 106

Alberto Martini

Alberto Martini

University of Genoa

Publications: 99

Brian M. Feldman

Brian M. Feldman

University of Toronto

Publications: 98

Rolando Cimaz

Rolando Cimaz

University of Milan

Publications: 83

Nico M Wulffraat

Nico M Wulffraat

Utrecht University

Publications: 82

Lisa G. Rider

Lisa G. Rider

National Institutes of Health

Publications: 63

Ronald M. Laxer

Ronald M. Laxer

University of Toronto

Publications: 62

Marco Gattorno

Marco Gattorno

Istituto Giannina Gaslini

Publications: 60

Daniel J. Lovell

Daniel J. Lovell

Cincinnati Children's Hospital Medical Center

Publications: 58

Dirk Foell

Dirk Foell

Boston Children's Hospital

Publications: 57

Fabrizio De Benedetti

Fabrizio De Benedetti

Bambino Gesù Children's Hospital

Publications: 49

Wendy Thomson

Wendy Thomson

University of Manchester

Publications: 46

Frederick W. Miller

Frederick W. Miller

National Institutes of Health

Publications: 44

Peter A. Nigrovic

Peter A. Nigrovic

Boston Children's Hospital

Publications: 43

Something went wrong. Please try again later.